When should antiretroviral therapy be started for HIV-infected infants in resource-limited settings?
Date
2008
Authors
Prendergast A.
Cottorr M.
Gibb D.M.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
[No abstract available]
Description
Keywords
antiretrovirus agent, cotrimoxazole, nevirapine, RNA directed DNA polymerase inhibitor, zidovudine, acquired immune deficiency syndrome, brain disease, clinical trial, combination chemotherapy, developmental disorder, disease course, disease transmission, drug dose titration, early diagnosis, editorial, growth disorder, health care planning, human, Human immunodeficiency virus infected patient, Human immunodeficiency virus infection, infant, infection prevention, monotherapy, mortality, perinatal care, practice guideline, single drug dose
Citation
Future HIV Therapy
2
3
2
3